{
  "docId": "019de074-1527-7308-955d-4c9eab2bbacb",
  "docSlug": "e812f3c221148b99b15c4527dea8f94b",
  "documentTitle": "argenx SE | Results Presentation Deck | 15 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 15,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "other",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide uses a timeline-based process flow to illustrate the clinical trial protocol.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de074-1527-7308-955d-4c9eab2bbacb/4",
  "deckHref": "/decks/019de074-1527-7308-955d-4c9eab2bbacb",
  "deckJsonHref": "/decks/019de074-1527-7308-955d-4c9eab2bbacb.json",
  "deckAnchorHref": "/decks/019de074-1527-7308-955d-4c9eab2bbacb#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.85,
        "x": 0.1,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Study design timeline showing screening, randomization, treatment period (24 weeks), and follow-up/extension.",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "57bc7b4a-81ab-4091-876a-2c82a2c80e7f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.65,
        "x": 0.25,
        "y": 0.7
      },
      "kind": "list",
      "text": "Eligibility criteria: Age >=18, Chronic/persistent ITP, platelet counts <30x10^9/L, prior treatments, concurrent therapy permitted.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "448a91bb-c361-4dc6-a19a-55a8d55f692b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.8,
        "x": 0.09,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "q2w if >=100x10^9/L for 3 of 4 visits... Concurrent oral corticosteroids, oral immunosuppressants, dapsone, danazol, fostamatinib, and oral thrombopoietin receptor agonists (not romiplostim).",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "39211466-ee13-49b3-ab87-4205bfc86f62",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.7,
        "x": 0.09,
        "y": 0.18
      },
      "kind": "subtitle",
      "text": "Phase 3, Multicenter, Double-blinded, Placebo-controlled, Randomized Clinical Trial",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7272f518-c8a0-473c-beb4-c466ee45e775",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.09,
        "y": 0.07
      },
      "kind": "title",
      "text": "ADVANCE IV (NCT04188379): Study Design",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4a807f86-0f8a-4ac3-ba18-3b9762a27193",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "4da6a5d4-c1be-4231-90ff-912f7760db2d",
      "evidence": "The slide uses a timeline-based visual to represent the clinical trial phases and dosing schedule.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}